To bridge this gap, we conducted a secondary analysis to evaluate the impact of a 16-week therapeutic yoga intervention on cognitive biomarkers like brain-derived neurotrophic factor (BDNF) and Nerve growth factor beta (β-NGF), metabolic markers (Leptin and Ghrelin), and inflammatory cytokines like monocyte chemoattractant protein-1 (MCP-1), tumor necrosis factor-beta (TNF-β), vascular endothelial growth factor-A (VEGF-A), and interleukin-12p70 (IL-12p70) in a heterogeneous cohort of cancer survivors. Here, CCL2 is linked to cancer.